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The paper entitled 'Effect of purified, soluble urokinase 
receptor on the plasminogen prourokinase activation system' 
by N. Behrendt and K. Dano was recently published in FEBS 
Letters [1]. In this paper the authors examined the effect of 
suPAR on plasminogen activation. Although they were able 
to confirm the results obtained by our group on the stimula-
tory effect of suPAR on scuPA activity [2,3], they reached 
contradictory conclusions i.e. that the stimulatory effect ob-
served by them was due to contamination of suPAR by pro-
teases and that the same was probably also the case in our 
experiments. These conclusions were based on two independ-
ent criteria: (1) the effect of ATF to block stimulation of 
scuPA activity by suPAR and (2) the concentration depend-
ence of the suPAR effect. 
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As far as the concentration dependence is concerned, the 
argument is that since increasing concentrations of suPAR 
above the apparent Kd, still has a stimulatory effect, this 
effect has to be ascribed to contamination by a protease. 
This argument is based on a mistaken interpretation of the 
data presented in Fig. 3B of their paper. From the data in Fig. 
1A, which show the initial velocity of the experiments pre-
sented in Fig. 3B of the paper by Behrendt and Dano, it 
can be seen that the effect of suPAR on scuPA activity is 
dose dependent and saturable. Saturation is already apparent 
at suPAR concentrations of 25 nM and half maximal stimu-
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lation was achieved at suPAR concentrations of 8 nM. The 
fact that the effect of suPAR is saturable cannot be ascribed 
to an increase in the concentration of a putative contaminant. 
If there were a contaminating enzyme present, the kinetic 
pattern should be as in Fig. IB of this communication. In 
other words, the activity of any enzyme is always proportional 
to its concentration. The experiment presented in Fig. 3B of 
the original paper should not be an exception, since the en-
zyme activity would not be limited by the concentration of 
scuPA, plasminogen or plasmin substrate (as can be seen in 
the experiment with 100 nM suPAR). The presence of a sat-
urable effect is in accordance with the postulate that the ob-
served stimulatory effect is the result of binding of ligand to 
receptor (scuPA to suPAR). 
The fact that dose dependence of suPAR can be observed 
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even at concentrations that are above the apparent K¿, does 
not exclude the possibility that suPAR exerts its effect through 
interaction with scuPA. The K¿ is determined by measuring 
the binding of scuPA to uPAR in a purified system and in the 
absence of plasmin(ogen) and plasmin substrate. Indeed, 
Spect-PL, at a concentration of 0.5 mM, is a competitive 
inhibitor of scuPA binding to uPAR (Higazi et al., unpub-
lished observations). In addition, the fact that scuPA binds to 
suPAR at several epitopes distributed among the three do-
mains of suPAR, with affinities significantly lower than the 
published K¿ [4], supports the possibility that some interac-
tions between scuPA and suPAR (that are important for the 
stimulation of scuPA) may take place only at high concentra-
tions and will only be present in equilibrium. 
The second criterion was the blocking effect of ATF (Fig. 
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Fig. 1. The effect of suPAR on scuPA-mediated plasminogen activation. A: Initial velocities were calculated from the curves presented in Fig. 
3B of the paper by Behrendt and Dano, by determining the slope of the linear portion of each curve. B: The theoretical kinetic pattern that 
would be obtained if a contaminating protease were present. 
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Fig. 2. The effect of ATF on suPAR-mediated stimulation. The 
data were taken from Fig. 2B of the paper by Behrendt and Dano. 
2B of the original paper) and the presentation of the same 
data in Fig. 2 of the present communication. The authors 
state that ATF did not affect the stimulation of the cascade 
resulting from the addition of suPAR. Looking carefully at 
Fig. 2B it is clear that at 10 min of incubation ATF totally 
abolished the stimulatory effect of suPAR and at 15 min there 
was still 50% inhibition. It is indeed to be expected that, under 
certain conditions, an inhibitory effect would be present only 
at early time points. The time-dependent decrease of the in-
hibitory effect of ATF is caused by the gradual activation of 
scuPA by the generated plasmin. The occurrence of such an 
effect is widely accepted by investigators, including the au-
thors of this paper. 
On the other hand, the data presented by Behrendt and 
Dano are apparently contradictory to previous results ob-
tained by the same group [5] and by Ellis [6] where no stim-
ulation of scuPA plasminogen activation by suPAR was 
found, although the putative contaminant should also have 
been present in their suPAR preparations. We recently found 
that the basis for the discrepancy between our results and 
those of Ellis was the use of different plasmin substrates. 
SuPAR has a stimulatory effect on scuPA activity when the 
plasmin substrate Spect-PL (American Diagnostics) is used, 
whereas an inhibitory effect was obtained with S-2251 
(Chromgenics) [7]. The fact that the stimulatory effect of su-
PAR on scuPA activity depends on the plasmin substrate used 
argues against the possibility that a contaminating protease is 
responsible for the stimulation obtained in the presence of 
suPAR. 
Finally, the fact that the stimulatory effect of suPAR on 
scuPA activity depends on the experimental conditions, does 
not preclude its existence and suggests that we are dealing 
with a sensitive and sophisticated system, capable of respond-
ing to environmental changes. 
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